Akcie - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Universal Health Services, Inc.

UHS

Valuace

Růst

Zdraví

Cena

$ 220.64

--4.31 (-2.11%)

Souhrn

Výkazy

Ukazatele

Profil

Držitelé

Návštěvnost webu

Konkurence

Zprávy společnosti

Kapitalizace

14.0B

Obrat

17B

Zisk

Aktiva

15B

Dluh

ROE

19%

ROA

Cena 1R

152-246

⌀ Cena

194.82

Dividenda

0.0(0.0%)

Čtvrtletní 10-Q

Celoroční 10-K

Nadcházející oznámení zisků

27-04-2026

Poslední dividenda

02-03-2026

Profil

Universal Health Services, Inc. prostřednictvím svých dceřiných společností vlastní a provozuje nemocnice akutní péče a ambulantní a behaviorální zdravotnická zařízení. Společnost působí v segmentech Acute Care Hospital Services a Behavioral Health Care Services. Jeho nemocnice nabízejí všeobecnou a specializovanou chirurgii, interní lékařství, porodnictví, pohotovostní péči, radiologii, onkologii, diagnostickou a koronární péči, pediatrické služby, lékárenské služby a/nebo behaviorální zdravotnické služby. K 24. únoru 2022 vlastnila a/nebo provozovala 363 lůžkových zařízení a 40 ambulantních a dalších zařízení nacházejících se v 39 státech; Washington, D.C.; Spojené království a Portoriko. Společnost také poskytuje komerční zdravotní pojištění a různé řídící služby, které zahrnují centrální nákup, informace, finanční a kontrolní systémy, plánování zařízení, nábor lékařů, administrativní personální management, marketing a public relations služby. Společnost Universal Health Services, Inc. byla založena v roce 1978 a sídlí v pruském králi v Pensylvánii.

Sektor

Healthcare

Odvětví

Medical - Care Facilities

Počet zaměstnanců

99300

Založení

1981-07-09

Adresa

Universal Corporate Center

CEO

Marc D. Miller

Web

uhs.com

Podobné společnosti

ENSG

The Ensign Group, Inc.

$ 179.21

- $ 0.76

ADUS

Addus HomeCare Corporation

$ 110.71

- $ 2.37

EHC

Encompass Health Corporation

$ 113.75

- $ 1.52

SGRY

Surgery Partners, Inc.

$ 16.60

- $ 4.90

HCA

HCA Healthcare, Inc.

$ 455.55

- $ 21.06

CYH

Community Health Systems, Inc.

$ 3.58

- $ 0.20

ACHC

Acadia Healthcare Company, Inc.

$ 18.50

- $ 1.01

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Rozvaha

Peněžní toky

V miliardách (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Revenues	17.36	17.36	15.83	14.28	13.40	12.64	11.56	11.38	10.77	10.41	9.77	9.04	8.07	7.28	6.96	7.50	5.57
Cost of Revenues	1.66	1.66	1.59	8.64	1.47	1.43	1.29	1.25	1.17	1.11	1.03	0.97	0.90	0.82	0.80	4.22	3.16
Gross Profit	15.71	15.71	14.24	5.64	11.93	11.21	10.27	10.13	9.60	9.30	8.73	8.07	7.17	6.46	6.16	3.28	2.41

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	4.49	4.50	4.28	4.10	4.11	3.96	3.91	3.84	3.70	3.56
Cost of Revenues	0.42	0.41	0.42	0.40	0.41	0.39	0.39	0.40	3.37	0.38
Gross Profit	4.06	4.08	3.87	3.70	3.71	3.57	3.52	3.44	0.33	3.18

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
R&D Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling General & Admin Expenses	0.00	0.00	0.00	7.25	6.89	6.28	5.73	5.70	5.36	5.08	4.68	4.31	3.94	3.70	3.54	0.09	0.13
Depreciation & Amortization	0.62	0.62	0.58	0.57	0.57	0.55	0.51	0.50	0.45	0.45	0.42	0.40	0.38	0.34	0.31	0.30	0.22
Total Operating Expenses	13.71	13.71	12.56	4.47	10.92	9.85	8.91	8.91	8.43	8.02	7.46	6.83	6.10	5.51	5.22	2.39	1.91
Operating Income	1.99	1.99	1.68	1.18	1.00	1.36	1.36	1.22	1.18	1.28	1.28	1.26	1.06	1.02	0.94	0.90	0.51

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling General & Admin Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.83	1.82
Depreciation & Amortization	0.16	0.16	0.15	0.15	0.15	0.15	0.15	0.14	0.15	0.14
Total Operating Expenses	3.55	3.56	3.36	3.24	3.24	3.19	3.08	3.05	2.98	-3.28
Operating Income	0.52	0.52	0.50	0.45	0.47	0.38	0.44	0.39	0.33	0.28

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00
Interest Expense	0.16	0.16	0.19	0.21	0.13	0.08	0.11	0.16	0.15	0.15	0.13	0.11	0.13	0.11	0.13	0.20	0.08
Other Expense	-0.02	-0.02	-0.18	-0.23	-0.14	-0.07	-0.11	-0.15	0.01	0.00	0.01	0.02	-0.01	0.04	-0.02	-0.20	-0.08
IBT	1.97	1.97	1.50	0.94	0.87	1.29	1.25	1.07	1.03	1.14	1.16	1.15	0.93	0.87	0.76	0.70	0.43
Income Tax Expense	0.46	0.46	0.33	0.22	0.21	0.31	0.30	0.24	0.24	0.36	0.41	0.40	0.32	0.32	0.27	0.25	0.15
Net Income	1.49	1.49	1.14	0.72	0.68	0.99	0.94	0.81	0.78	0.75	0.70	0.68	0.55	0.51	0.44	0.40	0.23

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.04	0.04	0.03	0.04	0.04	0.05	0.05	0.05	0.06	0.05
Other Expense	0.06	-0.02	-0.03	-0.03	-0.03	-0.04	-0.05	-0.05	-0.05	-0.06
IBT	0.58	0.50	0.47	0.42	0.44	0.34	0.38	0.34	0.28	0.23
Income Tax Expense	0.13	0.12	0.11	0.10	0.10	0.08	0.09	0.07	0.06	0.05
Net Income	0.45	0.37	0.35	0.32	0.33	0.26	0.29	0.26	0.22	0.17

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
EPS	$0.00	$0.00	$0.00	$10.35	$9.24	$11.99	$11.06	$9.16	$8.36	$7.86	$7.22	$6.89	$5.52	$5.21	$4.57	$4.09	$2.37
EPS Diluted	$0.00	$0.00	$0.00	$10.23	$9.15	$11.82	$10.99	$9.13	$8.32	$7.81	$7.14	$6.76	$5.42	$5.14	$4.53	$4.04	$2.34
Shares Outstanding	0.06	0.06	0.07	0.07	0.07	0.08	0.09	0.09	0.09	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10
Diluted Shares Outstanding	0.06	0.06	0.07	0.07	0.07	0.08	0.09	0.09	0.09	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$3.19	$2.42
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$3.16	$2.40
Shares Outstanding	0.06	0.06	0.06	0.06	0.07	0.07	0.07	0.07	0.07	0.07
Diluted Shares Outstanding	0.06	0.06	0.06	0.07	0.07	0.07	0.07	0.07	0.07	0.07

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Cash And Equivalents	0.13	0.13	0.12	0.10	0.12	1.22	0.06	0.11	0.07	0.03	0.06	0.03	0.02	0.02	0.04	0.03
Short Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Cash & ST Investments	0.13	0.13	0.12	0.10	0.12	1.22	0.06	0.11	0.07	0.03	0.06	0.03	0.02	0.02	0.04	0.03
Accounts Receivable	2.16	2.18	2.24	2.02	1.75	1.73	1.56	1.51	1.50	1.44	1.30	1.28	1.12	1.07	0.97	0.84
Inventory	0.22	0.22	0.22	0.22	0.21	0.19	0.16	0.15	0.14	0.13	0.12	0.11	0.10	0.10	0.10	0.09
Other Current Assets	0.24	0.29	0.24	0.20	0.19	0.14	0.13	0.17	0.09	0.08	0.10	0.08	0.08	0.09	0.10	0.25
Total Current Assets	2.74	2.82	2.81	2.54	2.26	3.28	1.92	1.94	1.80	1.68	1.72	1.62	1.43	1.41	1.36	1.33

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	0.11	0.14	0.13	0.13	0.11	0.13	0.11	0.12	0.08	0.08
Short Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Cash & ST Investments	0.11	0.14	0.13	0.13	0.11	0.13	0.11	0.12	0.08	0.08
Accounts Receivable	2.59	2.30	2.41	2.18	2.21	2.16	2.30	2.24	2.23	2.10
Inventory	0.23	0.22	0.22	0.22	0.22	0.22	0.22	0.22	0.21	0.22
Other Current Assets	0.33	0.33	0.32	0.29	0.26	0.24	0.24	0.24	0.22	0.23
Total Current Assets	3.26	2.99	3.08	2.82	2.80	2.74	2.87	2.81	2.75	2.62

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Property, Plant & Equipment	6.76	6.99	6.56	6.37	6.24	5.71	5.34	4.85	4.57	4.33	3.84	3.68	3.44	3.38	3.29	3.25
Goodwill	3.94	3.93	3.93	3.91	3.96	3.88	3.87	3.84	3.83	3.78	3.60	3.29	3.05	3.04	2.63	2.59
Intangible Assets	0.00	0.08	0.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Investments	0.30	0.32	0.31	0.00	0.01	0.00	0.01	0.01	0.01	0.01	-0.10	-0.07	-0.06	-0.03	0.00	-0.01
Other Long-Term Assets	0.22	0.22	0.27	0.61	0.57	0.57	0.52	0.62	0.55	0.51	0.45	0.35	0.33	0.30	0.27	0.25
Total Long-Term Assets	11.33	11.65	11.16	10.96	10.83	10.20	9.75	9.33	8.96	8.64	7.92	7.36	6.88	6.79	6.30	6.20
Total Assets	14.07	14.47	13.97	13.49	13.09	13.48	11.67	11.27	10.76	10.32	9.63	8.97	8.31	8.20	7.67	7.53

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	7.36	7.27	7.11	6.99	6.86	6.76	6.61	6.56	6.53	6.47
Goodwill	3.99	3.98	3.95	3.93	3.97	3.94	3.93	3.93	3.91	3.93
Intangible Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.08	0.00	0.00
Long-Term Investments	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.31	0.01	0.01
Other Long-Term Assets	0.60	0.26	0.61	0.61	0.60	0.52	0.55	0.27	0.57	0.59
Total Long-Term Assets	12.09	12.00	11.80	11.65	11.55	11.33	11.18	11.55	11.12	11.11
Total Assets	15.34	14.99	14.88	14.47	14.35	14.07	14.05	14.36	13.87	13.73

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Accounts Payable	1.93	0.63	0.61	1.76	1.86	1.66	1.27	1.38	1.28	1.21	1.03	1.11	0.28	0.25	0.23	0.82
Short-Term Debt	0.20	0.11	0.27	0.15	0.11	0.39	0.14	0.06	0.55	0.11	0.06	0.07	0.10	0.00	0.00	0.00
Other Current Liabilities	1.95	1.30	1.13	0.00	0.01	0.06	0.15	0.94	0.86	0.77	0.67	0.78	0.33	0.00	0.32	0.00
Current Liabilities	2.15	2.21	2.01	1.91	1.98	2.48	1.56	1.45	1.85	1.32	1.10	1.18	1.06	0.89	0.84	0.83

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	2.33	2.20	2.09	0.63	1.90	1.93	1.83	0.61	1.78	1.84
Short-Term Debt	0.81	0.11	0.12	0.11	0.11	0.20	0.20	0.27	0.27	0.26
Other Current Liabilities	0.01	0.01	0.00	1.30	0.00	0.00	0.00	1.13	-0.07	-0.07
Current Liabilities	3.16	2.32	2.33	2.21	2.01	2.15	2.08	2.01	1.99	2.04

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Long-Term Debt	4.42	4.84	5.10	5.12	4.45	3.80	4.17	3.94	3.49	4.03	3.39	3.21	3.21	3.73	3.65	3.91
Capital Leases	0.38	0.45	0.45	0.46	0.37	0.34	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Def. Tax Liability	0.00	0.00	0.00	0.00	0.00	0.01	0.03	0.05	0.05	0.09	0.32	0.28	0.24	0.18	0.21	0.17
Total Liabilities	7.52	7.71	7.77	7.52	6.90	7.07	6.09	5.80	5.70	5.71	5.08	4.94	4.79	5.20	5.10	5.50

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	4.30	4.89	4.98	4.84	5.00	4.80	5.11	5.10	5.18	4.99
Capital Leases	0.42	0.43	0.44	0.45	0.45	0.45	0.45	0.45	0.46	0.46
Def. Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.39	0.00	0.00
Total Liabilities	8.05	7.84	7.99	7.71	7.67	7.52	7.74	8.15	7.76	7.60

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	7.16	7.37	6.80	6.53	6.60	6.75	5.93	5.79	5.35	4.89	4.57	4.02	3.50	2.96	2.35	2.00
Comprehensive Income	-0.68	-0.71	0.01	-0.01	0.03	0.05	0.03	0.00	0.01	-0.03	-0.02	-0.03	-0.02	-0.04	-0.05	-0.02
Total Common Equity	6.49	6.67	6.15	5.92	6.09	6.32	5.50	5.39	4.99	4.53	4.25	3.74	3.25	2.71	2.30	1.98

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.06	6.09
Retained Earnings	0.00	7.71	7.49	7.37	7.27	7.16	6.92	6.80	6.72	6.71
Comprehensive Income	0.00	0.06	-0.70	-0.71	-0.66	-0.68	-0.67	-0.65	-0.66	0.01
Total Common Equity	7.23	7.03	6.79	6.67	6.61	6.49	6.26	6.15	6.06	6.09

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Debt		5.00	4.96	5.37	5.27	4.56	4.19	4.31	4.00	4.04	4.14	3.45	3.28	3.31	3.73	3.65	3.92
Book Value		6.56	6.76	6.20	5.97	6.20	6.41	5.58	5.47	5.06	4.61	4.55	4.03	3.52	3.00	2.57	2.02

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.06	0.12	0.10	0.10	0.08	0.07	0.05	0.05	0.05	0.05
Book Value		7.23	7.03	6.79	6.67	6.61	6.49	6.26	6.15	6.06	6.09

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Income	0.94	1.51	1.16	0.72	0.66	0.99	0.95	0.83	0.80	0.77	0.75	0.75	0.60	0.55	0.49	0.45	0.28
Depreciation & Amortization	0.57	0.62	0.58	0.57	0.58	0.53	0.51	0.49	0.45	0.45	0.42	0.40	0.38	0.34	0.31	0.30	0.22
Stock-Based Compensation	0.09	0.10	0.10	0.09	0.09	0.07	0.07	0.07	0.07	0.06	0.05	0.04	0.03	0.03	0.02	0.02	0.02
Change Working Capital	0.12	-0.28	0.42	0.02	-0.24	0.05	0.94	0.06	0.05	-0.01	0.16	-0.09	0.08	0.04	0.07	-0.04	-0.01
Change In Accounts Receivable	-0.03	-0.32	0.07	-0.18	-0.26	-0.01	-0.15	-0.04	-0.04	-0.02	-0.09	-0.05	-0.11	-0.05	-0.07	-0.13	0.02
Change In Accounts Payable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change In Inventories	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-cash Items	0.53	-0.09	-0.20	-0.12	-0.08	-0.79	-0.11	-0.10	-0.08	-0.08	-0.13	-0.13	-0.09	-0.09	-0.08	0.00	0.00
Cash from Operations	1.69	0.00	0.00	1.27	1.00	0.88	2.36	1.44	1.34	1.18	1.29	1.02	1.04	0.88	0.82	0.72	0.50

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	0.43	0.38	0.36	0.32	0.34	0.26	0.29	0.26	0.22	0.17
Depreciation & Amortization	0.16	0.16	0.15	0.15	0.15	0.15	0.15	0.14	0.15	0.14
Stock-Based Compensation	0.00	0.02	0.02	0.02	0.03	0.03	0.00	0.02	0.02	0.02
Change Working Capital	0.03	-0.10	0.07	-0.11	-0.13	-0.11	0.21	-0.03	0.07	-0.13
Change In Accounts Receivable	-0.02	-0.20	0.13	-0.22	0.06	-0.05	0.14	-0.07	0.01	-0.11
Change In Accounts Payable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change In Inventories	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-cash Items	-0.05	-0.08	-0.06	-0.02	0.28	0.01	0.03	0.00	0.00	-0.03
Cash from Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.45	0.16

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Capital Expenditure	-0.86	-1.02	-0.94	-0.74	-0.73	-0.86	-0.73	-0.66	-0.81	-0.61	-1.16	-0.91	-0.82	-0.37	-0.89	-0.32	-0.24
Acquisitions	0.01	-0.03	-0.02	0.00	-0.02	-0.11	-0.05	-0.01	-0.02	-0.02	-0.03	0.00	-0.01	-0.01	0.00	-0.03	-1.96
Investments	-0.01	-0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00
Sales of Investment	-0.02	0.00	0.00	0.00	0.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Investing Activities	0.02	0.00	0.00	-0.02	0.01	0.05	-0.01	-0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.09	0.07	0.00
Cash from Investing	-0.85	0.00	0.00	-0.76	-0.65	-0.91	-0.80	-0.69	-0.81	-0.62	-1.19	-0.91	-0.83	-0.38	-0.79	-0.29	-2.19

Cash Flow From Investing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure	-0.28	-0.25	-0.27	-0.24	-0.25	-0.25	-0.24	-0.21	-0.21	-0.20
Acquisitions	0.01	-0.04	0.00	-0.01	-0.01	0.00	0.00	0.01	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.03	0.02
Sales of Investment	0.00	0.00	0.00	0.00	0.00	-0.01	0.00	0.01	0.00	-0.02
Other Investing Activities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02
Cash from Investing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.24	-0.18

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Debt Repaid	-0.42	0.00	0.00	0.10	-0.09	-3.04	-0.96	-0.06	-0.83	-0.14	-0.46	-0.07	-0.88	-0.44	-0.85	-0.38	-1.39
Debt Issued	0.24	4.96	-0.41	0.19	0.80	3.40	0.85	0.37	0.79	0.05	1.15	0.24	0.85	0.02	0.93	0.12	5.31
Issuance of Common Stock	0.01	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00
Repurchase of Common Stock	-0.58	-0.97	-0.67	-0.55	-0.83	-1.22	-0.21	-0.77	-0.40	-0.36	-0.35	-0.21	-0.10	-0.03	-0.02	-0.06	-0.01
Dividends Paid	-0.05	0.00	0.00	-0.06	-0.06	-0.07	-0.02	-0.05	-0.04	-0.04	-0.04	-0.04	-0.03	-0.02	-0.06	-0.02	-0.02
Other Financing Activities	0.24	0.00	0.00	0.01	0.65	3.24	0.79	0.02	0.76	0.02	0.72	0.23	0.82	-0.03	0.88	0.04	3.13
Cash from Financing	-0.79	0.00	0.00	-0.49	-0.32	-1.07	-0.38	-0.85	-0.49	-0.52	-0.13	-0.08	-0.19	-0.51	-0.04	-0.42	1.71

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	0.20
Debt Issued	5.11	0.10	-0.09	0.14	-0.15	0.11	-0.31	-0.06	-0.01	0.41
Issuance of Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Repurchase of Common Stock	-0.35	-0.24	-0.16	-0.22	-0.25	-0.18	-0.10	-0.14	-0.16	-0.18
Dividends Paid	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.01
Other Financing Activities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash from Financing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.18	0.02

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Change in Cash		0.05	0.05	0.01	0.01	0.02	-1.10	1.17	-0.09	0.03	0.04	-0.03	0.03	0.01	-0.01	-0.02	0.01	0.02
Closing Cash Balance		0.13	0.27	0.22	0.21	0.20	0.18	1.28	0.11	0.20	0.07	0.03	0.06	0.03	0.02	0.02	0.04	0.03

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		0.02	-0.02	0.02	0.00	0.02	-0.02	0.02	-0.01	0.04	0.00
Closing Cash Balance		0.14	0.22	0.24	0.22	0.22	0.20	0.13	0.21	0.12	0.18

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Free Cash Flow		0.83	0.85	1.12	0.52	0.26	0.03	1.63	0.77	0.53	0.57	0.13	0.11	0.21	0.51	-0.08	0.39	0.26
Real Free Cash Flow		0.74	0.75	1.02	0.44	0.18	-0.05	1.56	0.71	0.46	0.52	0.09	0.07	0.18	0.49	-0.10	0.38	0.25

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		0.29	0.13	0.28	0.12	0.41	0.09	0.44	0.19	0.25	-0.04
Real Free Cash Flow		0.29	0.11	0.26	0.10	0.39	0.06	0.44	0.17	0.22	-0.06

Nacenění

Finance

Efektivita

Marže

Dividenda

Ostatní

Nacenění

Ukazatel	Aktuální	Historické	Konkurence
P/E	8	15.4	259.1
P/S	0.7	1	34.5
P/B	1.6	2.1	163.3
P/FCF	15.8	11.4	775.5
Market cap	$14.0	$11.5

P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel	Aktuální	Historické	Srovnání
Debt to Assets	33.3 %	37.3 %	0 %
Debt to Income	343.3 %	645 %	0 %
Debt to Free cash flow	673.4 %	10.4 %	0 %
Interest expense percentage	7.8 %	12.8 %	60.6 %
Current ratio	1	1.3	0